205 related articles for article (PubMed ID: 31485631)
1. Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer.
Liu Z; Zhu W; Kong X; Chen X; Sun X; Zhang W; Zhang R
Oncol Rep; 2019 Nov; 42(5):1893-1903. PubMed ID: 31485631
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.
Teng Z; Xu S; Lei Q
Oncol Rep; 2020 Feb; 43(2):503-515. PubMed ID: 31894340
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of tanshinone IIA and andrographolide on the apoptosis of cancer cells via crosstalk between p53 and reactive oxygen species pathways.
Li Y; Jiang B; Wang R; Wang J; Li Y; Bao Y
Pharmacol Rep; 2020 Apr; 72(2):400-417. PubMed ID: 32048269
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
Guan Z; Chen J; Li X; Dong N
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA exerts antitumor activity against vestibular schwannoma cells by inhibiting the expression of hypoxia-inducible factor-1α.
Kim JY; Song JJ; Kwon BM; Lee JD
Mol Med Rep; 2015 Sep; 12(3):4604-4609. PubMed ID: 26080622
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
Liu H; Liu C; Wang M; Sun D; Zhu P; Zhang P; Tan X; Shi G
Sci Rep; 2021 Sep; 11(1):19268. PubMed ID: 34588580
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells.
Dai ZK; Qin JK; Huang JE; Luo Y; Xu Q; Zhao HL
J Nat Med; 2012 Jan; 66(1):192-201. PubMed ID: 21853384
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone sensitized the antitumor effects of irradiation on laryngeal cancer via JNK pathway.
Xu H; Hao YL; Xu LN; Chen L; Xu FW
Cancer Med; 2018 Oct; 7(10):5187-5193. PubMed ID: 30239172
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65.
Su CC; Chien SY; Kuo SJ; Chen YL; Cheng CY; Chen DR
Mol Med Rep; 2012 Apr; 5(4):1019-22. PubMed ID: 22246196
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway.
Wang W; Li J; Ding Z; Li Y; Wang J; Chen S; Miao J
J Cell Mol Med; 2019 Sep; 23(9):6454-6465. PubMed ID: 31293090
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential.
Chiu TL; Su CC
Int J Mol Med; 2010 Feb; 25(2):231-6. PubMed ID: 20043132
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
Zhang YZ; Lai HL; Huang C; Jiang ZB; Yan HX; Wang XR; Xie C; Huang JM; Ren WK; Li JX; Zhai ZR; Yao XJ; Wu QB; Leung EL
Phytomedicine; 2024 Jun; 128():155431. PubMed ID: 38537440
[TBL] [Abstract][Full Text] [Related]
17. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Ang2/Tie2 Axis with Tanshinone IIA Elicits Vascular Normalization in Ischemic Injury and Colon Cancer.
Zou W; Qian C; Zhang S; Wan X; Wei Z; Li X; Wu Y; Chen W; Wang A; Zhao Y; Lu Y
Oxid Med Cell Longev; 2021; 2021():7037786. PubMed ID: 34804370
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.
Qiu Y; Li C; Wang Q; Zeng X; Ji P
Cancer Med; 2018 Feb; 7(2):397-407. PubMed ID: 29316373
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
Li X; Li Z; Li X; Liu B; Liu Z
BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
